Pfizer said on Wednesday it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries.
announced the program at the World Economic Forum’s annual gathering in Davos, Switzerland, and said it aims to improve health equity in 45 low-income countries. Most of the countries are in Africa, but the list also includes Haiti, Syria, Cambodia, and North Korea.
The products, which are widely available in the United States and the European Union, include 23 drugs and vaccines that treat infectious diseases, certain cancers, and rare and inflammatory diseases. Company spokeswoman Pam Eisele said only a small number of drugs and vaccines are currently available in all 45 countries.
New York-based Pfizer will charge only “minimal” manufacturing costs and distribution fees, Eisele said. He will comply with all penalties and all other applicable laws.
Earlier this month, the head of the World Health Organization called on Pfizer to make its COVID-19 treatment more widely available in poorer countries. Pfizer said its COVID-19 vaccine, Comirnaty, is already provided to poorer counties at a not-for-profit rate by the US government, which purchases the vaccines and then distributes them for free.
Comirnaty made nearly $37 billion in sales last year, and analysts expect the company’s COVID-19 treatment, Paxlovid, to add nearly $24 billion this year, according to the company. FactSet data.